title: Intravitreal injection of triamcinolone acetonide for immune recovery uveitis.
authors.affiliation: Save Sight Institute, Department of Clinical Ophthalmology, University of Sydney, Australia.
authors.forename: Maytinee
authors.initials: M
authors.lastname: Sirimaharaj
authors.forename: Michael R
authors.initials: MR
authors.lastname: Robinson
authors.forename: Meidong
authors.initials: M
authors.lastname: Zhu
authors.forename: Karl G
authors.initials: KG
authors.lastname: Csaky
authors.forename: Basil
authors.initials: B
authors.lastname: Donovan
authors.forename: Florian
authors.initials: F
authors.lastname: Sutter
authors.forename: Mark C
authors.initials: MC
authors.lastname: Gillies
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy / Q000276:immunology; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007267:Injections; D007964:Leukocytosis / Q000188:drug therapy* / Q000276:immunology; D008269:Macular Edema / Q000188:drug therapy / Q000209:etiology; D008297:Male; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*; D014605:Uveitis / Q000188:drug therapy* / Q000276:immunology; D014786:Vision Disorders / Q000188:drug therapy / Q000276:immunology; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D000998:Antiviral Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide